HTA58 Does NICE’s STA Process Effectively Reward the Value of Double-Branded Oncology Combinations, When Compared to Oncology Monotherapies?
| Autor: | K Legg, L Boland, P Craddy, G Foxon |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Value in Health. 25:S307 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2022.09.1518 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect